Japan · Delayed Price · Currency is JPY Genetec Statistics
Total Valuation
Genetec has a market cap or net worth of JPY 4.18 billion. The enterprise value is 4.66 billion.
| Market Cap | 4.18B |
| Enterprise Value | 4.66B |
Important Dates
The last earnings date was Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Genetec has 11.55 million shares outstanding. The number of shares has increased by 0.23% in one year.
| Current Share Class | 11.55M |
| Shares Outstanding | 11.55M |
| Shares Change (YoY) | +0.23% |
| Shares Change (QoQ) | +1.34% |
| Owned by Insiders (%) | 70.65% |
| Owned by Institutions (%) | n/a |
| Float | 3.03M |
Valuation Ratios
The trailing PE ratio is 8.27.
| PE Ratio | 8.27 |
| Forward PE | n/a |
| PS Ratio | 0.38 |
| PB Ratio | 1.53 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | 90.92 |
| P/OCF Ratio | 37.34 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.37, with an EV/FCF ratio of 101.27.
| EV / Earnings | 9.13 |
| EV / Sales | 0.42 |
| EV / EBITDA | 4.37 |
| EV / EBIT | 5.67 |
| EV / FCF | 101.27 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.76.
| Current Ratio | 1.49 |
| Quick Ratio | 1.34 |
| Debt / Equity | 0.76 |
| Debt / EBITDA | 1.95 |
| Debt / FCF | 45.07 |
| Interest Coverage | 27.37 |
Financial Efficiency
Return on equity (ROE) is 19.89% and return on invested capital (ROIC) is 15.67%.
| Return on Equity (ROE) | 19.89% |
| Return on Assets (ROA) | 7.30% |
| Return on Invested Capital (ROIC) | 15.67% |
| Return on Capital Employed (ROCE) | 21.08% |
| Weighted Average Cost of Capital (WACC) | 5.78% |
| Revenue Per Employee | 17.74M |
| Profits Per Employee | 823,910 |
| Employee Count | 619 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 31.79 |
Taxes
In the past 12 months, Genetec has paid 316.00 million in taxes.
| Income Tax | 316.00M |
| Effective Tax Rate | 38.26% |
Stock Price Statistics
The stock price has decreased by -17.73% in the last 52 weeks. The beta is 0.72, so Genetec's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -17.73% |
| 50-Day Moving Average | 454.58 |
| 200-Day Moving Average | 470.16 |
| Relative Strength Index (RSI) | 23.80 |
| Average Volume (20 Days) | 35,855 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genetec had revenue of JPY 10.98 billion and earned 510.00 million in profits. Earnings per share was 43.78.
| Revenue | 10.98B |
| Gross Profit | 4.15B |
| Operating Income | 821.00M |
| Pretax Income | 826.00M |
| Net Income | 510.00M |
| EBITDA | 1.07B |
| EBIT | 821.00M |
| Earnings Per Share (EPS) | 43.78 |
Balance Sheet
The company has 1.60 billion in cash and 2.07 billion in debt, with a net cash position of -476.00 million or -41.20 per share.
| Cash & Cash Equivalents | 1.60B |
| Total Debt | 2.07B |
| Net Cash | -476.00M |
| Net Cash Per Share | -41.20 |
| Equity (Book Value) | 2.73B |
| Book Value Per Share | 235.82 |
| Working Capital | 1.47B |
Cash Flow
In the last 12 months, operating cash flow was 112.00 million and capital expenditures -66.00 million, giving a free cash flow of 46.00 million.
| Operating Cash Flow | 112.00M |
| Capital Expenditures | -66.00M |
| Depreciation & Amortization | 244.00M |
| Net Borrowing | -190.00M |
| Free Cash Flow | 46.00M |
| FCF Per Share | 3.98 |
Margins
Gross margin is 37.77%, with operating and profit margins of 7.48% and 4.64%.
| Gross Margin | 37.77% |
| Operating Margin | 7.48% |
| Pretax Margin | 7.52% |
| Profit Margin | 4.64% |
| EBITDA Margin | 9.70% |
| EBIT Margin | 7.48% |
| FCF Margin | 0.42% |
Dividends & Yields
This stock pays an annual dividend of 19.50, which amounts to a dividend yield of 5.42%.
| Dividend Per Share | 19.50 |
| Dividend Yield | 5.42% |
| Dividend Growth (YoY) | 22.22% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 40.59% |
| Buyback Yield | -0.23% |
| Shareholder Yield | 5.09% |
| Earnings Yield | 12.19% |
| FCF Yield | 1.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 28, 2023. It was a forward split with a ratio of 3.
| Last Split Date | Dec 28, 2023 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Genetec has an Altman Z-Score of 3.38 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.38 |
| Piotroski F-Score | 6 |